BX Swiss - USA

BX Swiss - USA handeln
0,00 PKT ±0,00 PKT ±0,00 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Analysen zu BX Swiss - USA-Werten

Datum Rating Analyst
20.01.26 Bayer Overweight Barclays Capital
19.01.26 Bayer Kaufen DZ BANK
19.01.26 Boeing Buy Jefferies & Company Inc.
19.01.26 Bayer Buy Goldman Sachs Group Inc.
19.01.26 Bayer Neutral UBS AG
19.01.26 Bayer Overweight JP Morgan Chase & Co.
19.01.26 Bayer Hold Jefferies & Company Inc.
16.01.26 Nutrien (Ex Potash Agrium) Hold Jefferies & Company Inc.
16.01.26 Bayer Neutral UBS AG
15.01.26 Intel Sector Perform RBC Capital Markets
15.01.26 Boeing Outperform Bernstein Research
15.01.26 Nike Equal Weight Barclays Capital
15.01.26 NVIDIA Outperform RBC Capital Markets
14.01.26 Walmart Outperform RBC Capital Markets
14.01.26 JPMorgan Chase Halten DZ BANK
14.01.26 Boeing Buy UBS AG
14.01.26 JPMorgan Chase Overweight Barclays Capital
13.01.26 Boeing Outperform RBC Capital Markets
13.01.26 JPMorgan Chase Overweight Barclays Capital
13.01.26 Apple Overweight JP Morgan Chase & Co.
13.01.26 Boeing Buy Jefferies & Company Inc.
12.01.26 Oracle Overweight Barclays Capital
12.01.26 Microsoft Overweight Barclays Capital
12.01.26 JPMorgan Chase Overweight Barclays Capital
08.01.26 Pfizer Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
08.01.26 JPMorgan Chase Outperform RBC Capital Markets
07.01.26 Pfizer Neutral UBS AG
07.01.26 Bayer Overweight Barclays Capital
06.01.26 Apple Overweight JP Morgan Chase & Co.
06.01.26 Nike Outperform Bernstein Research
06.01.26 NVIDIA Outperform Bernstein Research
06.01.26 Chevron Outperform RBC Capital Markets
06.01.26 Nike Outperform RBC Capital Markets
06.01.26 Boeing Outperform Bernstein Research
05.01.26 Nike Neutral UBS AG
05.01.26 Oracle Buy UBS AG
05.01.26 Oracle Sector Perform RBC Capital Markets
05.01.26 Microsoft Outperform RBC Capital Markets
05.01.26 Boeing Outperform Bernstein Research
30.12.25 Apple Underweight Barclays Capital